Breaking
Friday, June 19, 2026

Drug Approvals

🇺🇸 FDA Page 13

FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page

Track global drug approvals & regulatory decisions. Gain critical intelligence on new therapies, market access, and competitive landscapes for pharma BD.

Showing 145–156 of 665 articles

High impact AnalysisJun 2, 2026

Experimental pancreatic cancer drug offers new hope in major trial

pancreatic cancer · 7 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

This Week in Breast Cancer: Camizestrant Delay, Bria-IMT Data, Recurrence Test

FDA · breast cancer · 9 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

Organon (OGN) to be Acquired by Sun Pharma for $14.00 Cash per Share

10 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

FDA Clears Iovance IL-12 TIL Trial, Signaling New Frontier in Solid Tumor Therapy

FDA · 8 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

FDA Approves Ensitrelvir for Post-Exposure Prophylaxis of COVID-19

FDA · COVID-19 · 8 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

FDA Issues Draft Guidance to Help Accelerate Cell and Gene Therapies for Patients

FDA · cell and gene therapies · 7 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

Personalized mRNA Cancer Vaccines: A New Era for Melanoma Treatment

melanoma · 7 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

Cumberland Pharmaceuticals (NASDAQ: CPIX) to divest marketed brands to Apotex for $100M

FDA · 10 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

FDA grants orphan status to oxaliplatin for hard-to-treat pancreatic cancer

FDA · pancreatic cancer · 9 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

Gilead Secures First Hepatitis D Drug Approval, Sparking Bay Area Competition

FDA · hepatitis · 9 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

FDA Approves MannKind's Afrezza for Pediatric Diabetes Patients

FDA · diabetes · 7 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

Elite Pharmaceuticals Announces Filing of Abbreviated New Drug Application with the U.S. Food and Drug Administration for Generic Anticoagulant Product

U.S. Food and Drug Administration · 10 min

Dr. Sarah Mitchell